Literature DB >> 7012143

Inactivation of yeast alpha-isopropylmalate synthase by CoA. Antagonism between CoA and adenylates and the mechanism of CoA inactivation.

D M Hampsey, G B Kohlhaw.   

Abstract

Yeast alpha-isopropylmalate synthase (EC 4.1.3.12) is inactivated by micromolar concentrations of CoA in the presence of Zn2+. We report here that rapid reactivation of inactivated enzyme (full recovery in less than 10 min) occurred in the presence of millimolar concentrations of ATP or ADP, using permeabilized cells. With purified, CoA-inactivated enzyme, ATP had only a weak reactivating effect which increased drastically, however, when a chelator was added at a concentration (0.1 mM) which by itself had little effect. Higher concentrations of chelator (1 mM) caused rapid reactivation even in the absence of ATP. Reactivation was also possible by removing CoA from equilibrium with oxidized glutathione, with acetyl phosphate in the presence of phosphotransacetylase, or by dialysis; however, these processes were very slow. Protection against CoA inactivation of alpha-isopropylmalate synthase was provided by high concentrations of ATP and, to a much lesser extent, ADP, by a high adenylate energy charge, by chelators, and by 3'-dephospho-CoA. Enzyme which had been inactivated with [3H]CoA did not retain any radioactivity (above control) when extracted with phenol. This result, together with other observations, is interpreted to mean that inactivation does not involve covalent modification, but is more likely the result of the formation of an enzyme.CoA.zinc complex held together by noncovalent forces. The physiological significance of the CoA effect is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012143

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Leucine biosynthesis in yeast : Identification of two genes (LEU4, LEU5) that affect α-Isopropylmalate synthase activity and evidence that LEU1 and LEU2 gene expression is controlled by α-Isopropylmalate and the product of a regulatory gene.

Authors:  V R Baichwal; T S Cunningham; P R Gatzek; G B Kohlhaw
Journal:  Curr Genet       Date:  1983-09       Impact factor: 3.886

2.  The yeast mitochondrial carrier Leu5p and its human homologue Graves' disease protein are required for accumulation of coenzyme A in the matrix.

Authors:  C Prohl; W Pelzer; K Diekert; H Kmita; T Bedekovics; G Kispal; R Lill
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 3.  Leucine biosynthesis in fungi: entering metabolism through the back door.

Authors:  Gunter B Kohlhaw
Journal:  Microbiol Mol Biol Rev       Date:  2003-03       Impact factor: 11.056

4.  Submitochondrial localization, cell-free synthesis, and mitochondrial import of 2-isopropylmalate synthase of yeast.

Authors:  D M Hampsey; A S Lewin; G B Kohlhaw
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

5.  Evidence that alpha-isopropylmalate synthase of Saccharomyces cerevisiae is under the "general" control of amino acid biosynthesis.

Authors:  Y P Hsu; G B Kohlhaw; P Niederberger
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

6.  Cloning and characterization of yeast Leu4, one of two genes responsible for alpha-isopropylmalate synthesis.

Authors:  L F Chang; T S Cunningham; P R Gatzek; W J Chen; G B Kohlhaw
Journal:  Genetics       Date:  1984-09       Impact factor: 4.562

7.  Overexpression of the peroxin Pex34p suppresses impaired acetate utilization in yeast lacking the mitochondrial aspartate/glutamate carrier Agc1p.

Authors:  Chalongchai Chalermwat; Thitipa Thosapornvichai; Parith Wongkittichote; John D Phillips; James E Cox; Amornrat N Jensen; Duangrurdee Wattanasirichaigoon; Laran T Jensen
Journal:  FEMS Yeast Res       Date:  2019-12-01       Impact factor: 2.796

8.  Pantothenate transport in Escherichia coli.

Authors:  D S Vallari; C O Rock
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.